Select Medical (NYSE:SEM – Get Free Report) had its price target upped by analysts at Royal Bank of Canada from $40.00 to $47.00 in a report released on Monday, Benzinga reports. The firm currently has an “outperform” rating on the health services provider’s stock. Royal Bank of Canada’s price target indicates a potential upside of 27.44% from the stock’s current price.
Other research analysts have also recently issued research reports about the stock. Benchmark restated a “buy” rating and issued a $48.00 target price on shares of Select Medical in a research report on Friday. Bank of America assumed coverage on shares of Select Medical in a research report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price for the company. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Select Medical currently has a consensus rating of “Moderate Buy” and a consensus target price of $40.75.
View Our Latest Stock Analysis on SEM
Select Medical Stock Up 2.6 %
Select Medical (NYSE:SEM – Get Free Report) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 17.56%. Select Medical’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.46 earnings per share. Equities analysts anticipate that Select Medical will post 2.03 earnings per share for the current year.
Institutional Investors Weigh In On Select Medical
Hedge funds have recently made changes to their positions in the company. GAMMA Investing LLC increased its stake in shares of Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock worth $81,000 after purchasing an additional 330 shares during the last quarter. Foster & Motley Inc. grew its position in Select Medical by 3.1% in the 2nd quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider’s stock worth $426,000 after purchasing an additional 370 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in Select Medical by 6.6% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock worth $198,000 after purchasing an additional 405 shares during the last quarter. Arizona State Retirement System grew its position in Select Medical by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider’s stock worth $1,071,000 after purchasing an additional 593 shares during the last quarter. Finally, Hexagon Capital Partners LLC lifted its holdings in shares of Select Medical by 528.7% during the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after acquiring an additional 645 shares during the period. Hedge funds and other institutional investors own 89.48% of the company’s stock.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Stories
- Five stocks we like better than Select Medical
- How to Evaluate a Stock Before Buying
- Intel: Is Now the Time to Be Brave?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- ETF Screener: Uses and Step-by-Step Guide
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.